MedTrace Logo

Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint

NCT03232749 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-06-14

Study results available
· View outcomes & findings →

Summary

This study will examine the effectiveness of a single cortisone injection in patients with shoulder osteoarthritis over a 6-month period, and identify clinical and radiographic factors to help predict how a patient with shoulder osteoarthritis will respond to a cortisone injection utilizing ultrasound guidance.

Conditions

  • Osteoarthritis of the Glenohumeral Joint

Interventions

PROCEDURE

intraarticular corticosteroid injections (IACSI)

ultrasound-guided IACSI will be administered

DRUG

corticosteroid injections

Corticosteroid will be administered is used to treat pain and swelling that occurs with arthritis and other joint disorder

DEVICE

Ultrasound

ultrasound-guided IACSI

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Bradley Schoch, M.D. · Faculty

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-18
Primary Completion
2019-06-06
Completion
2019-06-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03232749 on ClinicalTrials.gov